Arbutus Biopharma Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Arbutus Biopharma

ABUS 4.840

+4.9%

3:59 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: donpat who wrote (22)	8/2/2014 9:51:35 AM
From: scion	of 42

Human Ebola Virus Species and Compositions and Methods Thereof US 20120251502 A1 Abstract Compositions and methods including and related to the Ebola Bundibugyo virus (EboBun) are provided. Compositions are provided that are operable as immunogens to elicit and immune response or protection from EboBun challenge in a subject such as a primate. Inventive methods are directed to detection and treatment of EboBun infection. Publication number US20120251502 A1 Publication type Application Application number US 13/125,890 PCT number PCT/US2009/062079 Publication date Oct 4, 2012 Filing date Oct 26, 2009 Priority date Oct 24, 2008 Also published as CA2741523A1, 4 More » Inventors Jonathan S. Towner, 4 More » Original Assignee The Government of the US as Represented by the Secretary of the Dept. of health Export Citation BiBTeX, EndNote, RefMan Patent Citations (2), Non-Patent Citations (8), Classifications (39), Legal Events (1) google.com

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next